| Literature DB >> 26374428 |
Jonine D Figueroa1, Stella Koutros1, Joanne S Colt1, Manolis Kogevinas1, Montserrat Garcia-Closas1, Francisco X Real1, Melissa C Friesen1, Dalsu Baris1, Patricia Stewart1, Molly Schwenn1, Alison Johnson1, Margaret R Karagas1, Karla R Armenti1, Lee E Moore1, Alan Schned1, Petra Lenz1, Ludmila Prokunina-Olsson1, A Rouf Banday1, Ashley Paquin1, Kris Ylaya1, Joon-Yong Chung1, Stephen M Hewitt1, Michael L Nickerson1, Adonina Tardón1, Consol Serra1, Alfredo Carrato1, Reina García-Closas1, Josep Lloreta1, Núria Malats1, Joseph F Fraumeni1, Stephen J Chanock1, Nilanjan Chatterjee1, Nathaniel Rothman1, Debra T Silverman1.
Abstract
Few studies have demonstrated gene/environment interactions in cancer research. Using data on high-risk occupations for 2258 case patients and 2410 control patients from two bladder cancer studies, we observed that three of 16 known or candidate bladder cancer susceptibility variants displayed statistically significant and consistent evidence of additive interactions; specifically, the GSTM1 deletion polymorphism (P interaction ≤ .001), rs11892031 (UGT1A, P interaction = .01), and rs798766 (TMEM129-TACC3-FGFR3, P interaction = .03). There was limited evidence for multiplicative interactions. When we examined detailed data on a prevalent occupational exposure associated with increased bladder cancer risk, straight metalworking fluids, we also observed statistically significant additive interaction for rs798766 (TMEM129-TACC3-FGFR3, P interaction = .02), with the interaction more apparent in patients with tumors positive for FGFR3 expression. All statistical tests were two-sided. The interaction we observed for rs798766 (TMEM129-TACC3-FGFR3) with specific exposure to straight metalworking fluids illustrates the value of integrating germline genetic variation, environmental exposures, and tumor marker data to provide insight into the mechanisms of bladder carcinogenesis. Published by Oxford University Press 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26374428 PMCID: PMC4675099 DOI: 10.1093/jnci/djv223
Source DB: PubMed Journal: J Natl Cancer Inst ISSN: 0027-8874 Impact factor: 13.506